TITLE

Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats

AUTHOR(S)
Thirunavukkarasu, C.; Yang, Y.; Subbotin, V. M.; Harvey, S. A. K.; Fung, J.; Gandhi, C. R.
PUB. DATE
July 2004
SOURCE
Gut;Jul2004, Vol. 53 Issue 7, p1010
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Hepatic concentrations of the powerful vasoconstrictor and fibrogen endothelin 1 (ET-1) and its receptors increase in human and experimental cirrhosis, suggesting a major role for ET-1 in the pathology of chronic liver disease. We investigated whether ET-1 receptor antagonism, after the development of fibrosis and cirrhosis, arrests/reverses the progression of chronic liver disease. Methods: Chronic liver injury was induced in rats by carbon tetrachloride (CCl4) treatment (0.15 ml/kg intraperitoneally twice a week) in conjunction with phenobarbital in drinking water (0.4 g/l) for four (group 1: fibrosis) and eight (group 2: cirrhosis) weeks. Rat were then treated concurrently with the ET-1 receptor antagonist TAK-044 (10 mg/kg/day) and CCl4/phenobarbital for a further four weeks. Results: Histopatbological examination revealed significant arrest of progression to cirrhosis in group 1 and reversal of cirrhosis in group 2 rats. TAK-044 treatment caused significant amelioration of portal hypertension, systemic hypotension, and liver injury (reduced activities of serum aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase), and improved hepatic synthetic capacity (increased serum albumin concentration) in both groups of rats relative to vehicle treated rats. TAK-044 treatment reduced collagen synthesis, as evidenced by decreased hepatic hydroxyproline content, mRNA expression of collagen-α type I, and tissue inhibitors of matrix metalloproteinases 1 and 2, and mRNA and protein expression of a potent fibrogenic cytokine, transforming growth factor β1. Conclusions: The results emphasise the role of ET-1 in the development of cirrhosis and strongly suggest that blockade of its actions can be a rational therapy for chronic liver disease and its complications.
ACCESSION #
13870133

 

Related Articles

  • Hepatic Tissue Endothelin-1 Levels in Chronic Liver Disease Correlate With Disease Severity and Ascites. Alam, I.; Bass, N. M.; Bacchetti, P.; Gee, L.; Rockey, D. C. // American Journal of Gastroenterology;Jan2000, Vol. 95 Issue 1, p199 

    OBJECTIVES: Plasma endothelin-1 (ET-1) levels are increased in patients with cirrhosis and ET-1 production is increased in the liver itself during experimental injury. These data suggest a possible role for this vasoactive peptide in intrahepatic microcirculatory changes that contribute to the...

  • Doses of endothelin have natriuretic effects in conscious rats with cirrhosis and ascites. Clària, Joan; Jiménez, Wladimiro; Arroyo, Vicente; Castro, Anna; Asbert, Mònica; Ros, Josefa; Rivera, Francisca; Rodés, Joan // Kidney International;Aug1991, Vol. 40 Issue 2, p182 

    MAP, RPF, GFR, V and UNa V were measured in nine conscious control and in 11 conscious cirrhotic rats with ascites before and following two bolus injections (100 and 600 pmol/kg body wt) of endothelin (ET). PRA and plasma concentration of aldosterone and ANP were measured in basal conditions and...

  • Pathology/cytology.  // Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS76 

    Presents an abstract of the research manuscript `Endothelin 1 (ET-1) and endothelin 3 (ET-3) like immunoreactivity in normal and cirrhotic liver and in hepatocellular carcinoma,' by S. Chakrabarti and K. Mukherjee.

  • Hematochezia in a patient with liver cirrhosis. Cahill, Ronan A.; Norris, Suzanne; Stephens, Richard B. // World Journal of Emergency Surgery;2007, Vol. 2, p32 

    Although commonly detectable in patients with cirrhosis, rectal varices only infrequently cause significant hematochezia (0.5-3.6%). While they may be expected to resolve with treatment of the concomitant portal hypertension, there is currently no standardized approach to their management in...

  • ROLE OF ENQOTHELIN-1 IN THE MAINTENANCE OF SYSTEMIC AND PORTAL HAEMODYNAMICS IN PATIENTS WITH CIRRHOSIS: A RANDOMISED DOUBLE BLIND PLACEBO CONTROLLED HAEMODYNAMIC STUDY... Tripathi, D.; Therapondos, G.; Ferguson, J. W.; Webb, D. J.; Newby, D. E.; Hayes, P. C. // Gut;Apr2004 Supplement 3, Vol. 53, pA13 

    Endothelin (ET)-1 synthesis and receptor expression are increased in the injured liver. To date, there are no studies to examine the role of ET-1 on systemic and portal haemodynamics in patients with cirrhosis. For the first time, researchers have shown that ET-1 contributes to the maintenance...

  • Management Challenges of Liver Cirrhosis. Sadovsky, Richard // American Family Physician;2/15/2000, Vol. 61 Issue 4, p1127 

    Provides information on the study `Cirrhosis of Liver,' by B.S. Anand published in the August 1999 issue of the `Western Journal of Medicine.'

  • Mercaptopurine.  // Reactions Weekly;Aug2014, Vol. 1512 Issue 1, p27 

    The article presents a case study of a 12-year-old boy who was admitted to hospital for non-cirrhotic portal hypertension after being treated for Cohn's disease (CD).

  • DECOMPENSATED CIRRHOSIS; PREVALENCE OF GASTRIC VARICES. Iqbal, Sarwat; Yousaf, Muhammad Haroon; Yousuf, Muhammad Ifitikhar; Wasim-Uddin // Professional Medical Journal;2015, Vol. 22 Issue 11, p1397 

    Cirrhosis with subsequent portal hypertension is a major health problem worldwide. Among various etiologies, HCV is the leading cause of chronic hepatocellular injury. Cirrhosis being the commonest cause of portal hypertension results in a spectrum of complications. Approximately 5-15% of...

  • Idiopathic Presinusoidal Portal Hypertension (Banti's Syndrome). Polish, Edwin; Christie, John; Cohen, Arthur; Sullivan Jr., Benjamin // Annals of Internal Medicine;Apr62, Vol. 56 Issue 4, p624 

    Presents the case of a 23-year-old Caucasian male that bears resemblance to the early stages of Banti's syndrome, characterized by splenomegaly and cirrhosis of the liver. Stages of the disease; Indications that the portal hypertension was presinusoidal in origin; Absence of neurological...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics